Resources

The Impact of the COVID‑19 Pandemic on Opioid-Related Harm in Ontario

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 8, 2021

Heparin Anticoagulation for Hospitalized Patients with COVID-19

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 3, 2021

SARS-CoV-2 Transmission Among Health Care Workers and the General Population Following Vaccination

Product: — Evidence Synthesis Network

Clinicians Community Prevention & Transmission Healthcare Workers Transmission Vaccine Vaccines & Immunity

esnetwork.ca Last Updated: September 3, 2021

SARS-CoV-2 transmission: Findings and proposed terminology

Product: — Institut national de santé publique du Québec

About Coronavirus Transmission

www.inspq.qc.ca Last Updated: July 9, 2021

COVID-19 Vaccination for People with Disabilities

Product: — Science Table

Health Status Public Health & Implementation Vaccine Vaccines & Immunity Vulnerable Groups Vulnerable Sub-populations

covid19-sciencetable.ca Last Updated: June 15, 2021

Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID‑19 Vaccines

Product: — Science Table

Disease Mechanism Infectious Diseases & Clinical Care Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: May 11, 2021

Indoor Versus Outdoor Transmission of COVID-19

Product: — Evidence Synthesis Network

About Coronavirus Transmission

esnetwork.ca Last Updated: March 26, 2021

Aerosol-Generating Medical Interventions on Suspected and Confirmed Cases of COVID-19

Product: — Institut national de santé publique du Québec

About Coronavirus Aerosols Transmission

www.inspq.qc.ca Last Updated: March 17, 2021

Also available in Français

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Treatments

covid19-sciencetable.ca Last Updated: February 25, 2021

Best Practices for Limiting the Transmission of COVID‑19 Variants of Concern

Product: — Evidence Synthesis Network

Community Prevention & Transmission Public Prevention Transmission

esnetwork.ca Last Updated: February 24, 2021